A behavioral and molecular study; ameliorated anxiety-like behavior and cognitive dysfunction in a rat model of chronic unpredictable stress treated with oregano extract.
Animals
Anxiety
/ drug therapy
Brain-Derived Neurotrophic Factor
/ metabolism
Cognitive Dysfunction
/ drug therapy
Disease Models, Animal
Hippocampus
/ metabolism
Male
Origanum
/ metabolism
RNA, Messenger
/ metabolism
Rats
Stress, Psychological
/ complications
Toll-Like Receptor 2
/ metabolism
Toll-Like Receptor 4
/ metabolism
Origanum vulgare L.
anxiety-like behavior
behavioral tests
chronic unpredictable stress
cognitive dysfunction
gene expression
toxicity assessment
Journal
Brain and behavior
ISSN: 2162-3279
Titre abrégé: Brain Behav
Pays: United States
ID NLM: 101570837
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
revised:
01
06
2022
received:
11
03
2022
accepted:
12
07
2022
pubmed:
29
7
2022
medline:
24
8
2022
entrez:
28
7
2022
Statut:
ppublish
Résumé
Chronic stress is considered a severe risk factor leading to various disorders, including anxiety and cognitive decline. The present study aimed to investigate the effects of Origanum vulgare (oregano) extract on improving anxiety-like behavior and learning and memory defection caused by chronic unpredictable stress (CUS). A 10-day CUS protocol was executed on male rats, and on day 10, their anxiety, learning, and memory status were evaluated. After that, in addition to the CUS, the rats were treated with the oregano extract for 2 weeks. Then, the expression of BDNF, TrkB, and TLR2/4 genes in the hippocampus and prefrontal cortex of the rats was evaluated. Also, the liver- and kidney-related serum parameters, including triglycerides, total cholesterol, HDL, LDL, creatinine, urea, serum glucose, alanine aminotransferase, and aspartate aminotransferase were assessed. Further, the extract's lethal effect and its impact on animals' body weight were investigated. Behavioral tests confirmed the anxiety-like behavior and learning-memory function impairment caused by CUS. In contrast, the administration of the extract could significantly alleviate the mental deficiencies and diminished anxiety-like behaviors. Molecular assessments showed that CUS could markedly decrease the BDNF and TrkB genes' expression levels while increasing that of TLR2 and TLR4. In contrast, in extract-treated animals, mRNA levels of BDNF and TrkB considerably increased, yet TLR2 and TLR4 mRNA levels reduced. Additionally, consumption of the extract caused weight gain, while having no lethality and detrimental effect on the liver and kidneys functions. These findings indicate the anxiolytic properties of the extract and its improving effect on cognitive dysfunction.
Identifiants
pubmed: 35898162
doi: 10.1002/brb3.2727
pmc: PMC9392516
doi:
Substances chimiques
Brain-Derived Neurotrophic Factor
0
RNA, Messenger
0
Toll-Like Receptor 2
0
Toll-Like Receptor 4
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2727Informations de copyright
© 2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC.
Références
Antioxidants (Basel). 2020 Sep 26;9(10):
pubmed: 32993114
Fundam Clin Pharmacol. 2010 Aug;24(4):437-43
pubmed: 19909350
Arch Physiol Biochem. 2019 Feb;125(1):56-63
pubmed: 29425067
J Biomed Sci. 2019 Nov 4;26(1):90
pubmed: 31684953
Neuron. 2018 Aug 8;99(3):464-479.e7
pubmed: 30033154
Biotechnol Rep (Amst). 2019 Nov 09;24:e00393
pubmed: 31763203
Psychoneuroendocrinology. 2018 Nov;97:8-19
pubmed: 29990678
J Neurotrauma. 2012 Jul 1;29(10):1941-59
pubmed: 22583372
Int J Neurosci. 2017 Dec;127(12):1096-1103
pubmed: 28562144
Vet World. 2020 Sep;13(9):1870-1874
pubmed: 33132599
J Neurosci. 2007 Mar 14;27(11):2781-7
pubmed: 17360899
Am J Drug Alcohol Abuse. 2020 May 3;46(3):304-315
pubmed: 31609135
J Tradit Complement Med. 2021 Sep 25;12(4):345-353
pubmed: 35747351
Behav Brain Res. 2014 Sep 1;271:116-21
pubmed: 24914461
Lasers Med Sci. 2020 Apr;35(3):573-584
pubmed: 31372913
Eur J Pharmacol. 2020 Feb 15;869:172857
pubmed: 31837991
Commun Agric Appl Biol Sci. 2013;78(2):167-72
pubmed: 25145237
Sci Rep. 2016 Mar 23;6:23441
pubmed: 27006086
Neuropsychopharmacology. 2008 Jan;33(2):320-31
pubmed: 17406647
Clin Exp Pharmacol Physiol. 2019 Apr;46(4):360-372
pubmed: 30620416
Metab Brain Dis. 2013 Mar;28(1):77-84
pubmed: 23263992
Arch Latinoam Nutr. 2004 Mar;54(1):100-11
pubmed: 15332363
Mol Med Rep. 2017 Oct;16(4):4987-4993
pubmed: 28791385
Pharmacol Rep. 2011;63(2):537-43
pubmed: 21602609
Front Mol Neurosci. 2010 Feb 09;3:1
pubmed: 20162032
Behav Brain Res. 2021 Jan 1;396:112896
pubmed: 32905811
Neurobiol Aging. 2012 Jun;33(6):1122.e23-39
pubmed: 22209410
Mol Biol Rep. 2020 Oct;47(10):7709-7722
pubmed: 32959196
Br J Nutr. 2011 Apr;105(8):1150-63
pubmed: 21205415
Brain Behav. 2022 Aug;12(8):e2727
pubmed: 35898162
Res Pharm Sci. 2018 Apr;13(2):130-141
pubmed: 29606967
Theriogenology. 2005 Feb;63(3):716-21
pubmed: 15629791
Am J Psychiatry. 2017 Dec 1;174(12):1137-1139
pubmed: 29191031
Can J Physiol Pharmacol. 2020 Oct;98(10):717-724
pubmed: 32516558